Characteristics and risk factors of major and clinically relevant non-major bleeding in cancer patients receiving anticoagulant treatment for acute venous thromboembolism - the CATCH study

被引：0
|
作者：
Kamphuisen, P. W. [1 ]
Lee, A. Y. Y. [2 ,3 ]
Meyer, G. [4 ]
Bauersachs, R. [5 ]
Janas, M. S. [6 ]
Jarner, M. F. [6 ]
Khorana, A. A. [7 ]
机构：
[1] Univ Med Ctr Groningen, Dept Vasc Med, NL-9713 AV Groningen, Netherlands
[2] Univ British Columbia, Div Hematol, Vancouver, BC V5Z 1M9, Canada
[3] Vancouver Coastal Hlth, Vancouver, BC, Canada
[4] Georges Pompidou European Hosp, Resp Unit, Paris, France
[5] Darmstadt Hosp, Dept Vasc Med, Darmstadt, Germany
[6] LEO Pharma, Ballerup, Denmark
[7] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR228
引用
收藏
页码：182 / 183
页数：2
相关论文
共 50 条
  • [41] Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study
    Evans, Alison
    Davies, Miranda
    Osborne, Vicki
    Roy, Debabrata
    Shakir, Saad
    PLOS ONE, 2020, 15 (10):
  • [42] The Risk of Major Bleeding in Patients Treated with Warfarin for Venous Thromboembolism at an Anticoagulation Clinic: An Incident User Cohort Study
    Johnson, Eric S.
    Smith, David H.
    Yang, Xiuhai
    Petrik, Amanda F.
    Weiss, Jessica R.
    Thorp, Micah L.
    Felcher, Andrew H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S146 - S146
  • [43] Risk Factors for Major Bleeding during Prolonged Anticoagulation Therapy in Patients with Venous Thromboembolism: From the COMMAND VTE Registry
    Kim, Kitae
    Yamashita, Yugo
    Morimoto, Takeshi
    Kitai, Takeshi
    Yamane, Takafumi
    Ehara, Natsuhiko
    Kinoshita, Makoto
    Kaji, Shuichiro
    Amano, Hidewo
    Takase, Toru
    Hiramori, Seiichi
    Oi, Maki
    Akao, Masaharu
    Kobayashi, Yohei
    Toyofuku, Mamoru
    Izumi, Toshiaki
    Tada, Tomohisa
    Chen, Po-Min
    Murata, Koichiro
    Tsuyuki, Yoshiaki
    Saga, Syunsuke
    Sasa, Tomoki
    Sakamoto, Jiro
    Kinoshita, Minako
    Togi, Kiyonori
    Mabuchi, Hiroshi
    Takabayashi, Kensuke
    Shiomi, Hiroki
    Kato, Takao
    Makiyama, Takeru
    Ono, Koh
    Furukawa, Yutaka
    Kimura, Takeshi
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (09) : 1498 - 1507
  • [44] Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study
    Verso, Melina
    Agnelli, Giancarlo
    Munoz, Andres
    Connors, Jean M.
    Sanchez, Olivier
    Huisman, Menno
    Brenner, Benjamin
    Gussoni, Gualberto
    Cohen, Alexander T.
    Becattini, Cecilia
    EUROPEAN JOURNAL OF CANCER, 2022, 165 : 136 - 145
  • [45] Long-term anticoagulation for the treatment and secondary prophylaxis of venous thromboembolism among men with prostate cancer in Sweden: risk of recurrent venous thromboembolism and major bleeding
    Brobert, G.
    Farahmand, B.
    Stattin, P.
    Garmo, H.
    Balabanova, Y.
    THROMBOSIS RESEARCH, 2021, 200 : S40 - S40
  • [46] Major Bleeding Events Among Cancer and Non-Cancer Patients Taking Rivaroxaban for Venous Thromboembolism Treatment in a Department of Defense Health System Cohort
    Khorana, Alok A.
    Peacock, Frank
    Tamayo, Sally G.
    Yuan, Zhong
    Sicignano, Nicholas
    Hopf, Kathleen
    Patel, Manesh
    BLOOD, 2016, 128 (22)
  • [47] Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?
    Xu, Ke
    Chan, Noel C. C.
    THROMBOSIS AND HAEMOSTASIS, 2023, 123 (05) : 487 - 489
  • [48] Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry -
    Nishimoto, Yuji
    Yamashita, Yugo
    Kim, Kitae
    Morimoto, Takeshi
    Saga, Syunsuke
    Amano, Hidewo
    Takase, Toru
    Hiramori, Seiichi
    Oi, Maki
    Akao, Masaharu
    Kobayashi, Yohei
    Toyofuku, Mamoru
    Izumi, Toshiaki
    Tada, Tomohisa
    Chen, Po-Min
    Murata, Koichiro
    Tsuyuki, Yoshiaki
    Sasa, Tomoki
    Sakamoto, Jiro
    Kinoshita, Minako
    Togi, Kiyonori
    Mabuchi, Hiroshi
    Takabayashi, Kensuke
    Yoshikawa, Yusuke
    Shiomi, Hiroki
    Kato, Takao
    Makiyama, Takeru
    Ono, Koh
    Sato, Yukihito
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2020, 84 (11) : 2006 - +
  • [49] Retrospective Real-World Analysis of the Primary Safety Outcomes in Venous Thromboembolism of High-Risk Major Bleeding Cancer Patients Receiving Therapeutic Anticoagulation
    Brucks, Eric Brucks
    Veeravelli, Sumana
    Halder, Ritika
    Martinez, Francisco Javier
    Leiva, Jorge Andres
    Saboda, Kathylynn
    Roe, Denise
    Babiker, Hani M.
    McBride, Ali
    Recio-Boiles, Alejandro
    BLOOD, 2020, 136
  • [50] Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice
    Giorgi-Pierfranceschi, Matteo
    Di Micco, Pierpaolo
    Cattabiani, Chiara
    Guida, Anna
    Pagan, Barbara
    del Valle Morales, Maria
    Salgado, Estuardo
    Maria Surinach, Jose
    Tolosa, Carles
    Monreal, Manuel
    MEDICINE, 2015, 94 (47) : e1944
12345